NCT00989417View on ClinicalTrials.gov

Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring

NACompletedINTERVENTIONAL

Enrollment

473

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Implantable Cardioverter-DefibrillatorsVentricular FibrillationTachycardia, Ventricular

Interventions

OTHER

ACTIVATION of HOME MONITORING

Both patient groups will be followed for 27 months and will have Home Monitoring switched on. The data from the CONTROL group will not be presented online to the attending physician, but a retrospective analysis on differences between the two groups will be performed.

Trial Locations (1)

Unknown

CHRU de Lille- Hôpital Cardiologique, Lille

All Listed Sponsors

lead

Biotronik SE & Co. KG

INDUSTRY

NCT00989417 - Benefits of Implantable Cardioverter Defibrillator Follow-up Using Remote Monitoring | Biotech Hunter | Biotech Hunter